Prevalence of melanocortin 4 receptor (MC4R) mutations and polymorphisms in consecutively ascertained obese children and adolescents from a pediatric health care utilization population;Prävalenz von melanocortin-4-rezeptor(MC4R)-mutationen und polymorphismen bei adipösen kindern und jugendlichen in einer konsekutiven pädiatrischen inanspruchnahmepopulation

Klinische Padiatrie

Volumn 217, Issue 4, 2005, Pages 244-249

  Zakel, U A ^a   Wudy, S A ^a   Heinzel Gutenbrunner, M ^b   Gorg T ^b   Schafer H ^b   Gortner, L ^d   Blum, W F ^a   Hebebrand, J ^c   Hinney, A ^c  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c UNIVERSITY OF DUISBURG ESSEN   (Germany)

^d SAARLAND UNIVERSITY   (Germany)

Author keywords

Childhood; Insulin; Leptin; MC4 receptor gene; Metabolic risk factors; Obesity

Indexed keywords

MELANOCORTIN 4 RECEPTOR;

ADOLESCENT; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; BODY WEIGHT; CARDIOVASCULAR RISK; CHILD; CORRELATION ANALYSIS; ECHOGRAPHY; FEMALE; FOOD INTAKE; GENE MUTATION; GENETIC POLYMORPHISM; HEALTH CARE UTILIZATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERTRIGLYCERIDEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; MC4R GENE; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PHENOTYPE; PREVALENCE; RECEPTOR GENE; REFERENCE VALUE; REGULATORY MECHANISM; RISK ASSESSMENT; RISK FACTOR;

ADOLESCENT; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; GLUCOSE TOLERANCE TEST; HETEROZYGOTE DETECTION; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; MUTATION; OBESITY; PHENOTYPE; POLYMORPHISM, GENETIC; RECEPTOR, MELANOCORTIN, TYPE 4; RISK; RISK FACTORS; WAIST-HIP RATIO;

EID: 22244479316     PISSN: 03008630     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-836589     Document Type: Article

References (38)

1. Ahima RS, Flier JS. Leptin. Annu Rev Physiol 2000; 62: 413-437
2. th ed. WB Sanders Company 2003
3. Benecke A, Vogel H. Übergewicht und Adipositas. In: Robert Koch-Institut (Hrsg). Gesundheitsberichtserstattung des Bundes. Heft 16. Berlin 2003
4. Biebermann H, Krude H, Elsner A, Chubanov V, Gudermann T, Gruters A. Autosomal-dominant mode of inheritance of a melanocortin-4 receptor mutation in a patient with severe early-onset obesity is due to a dominant-negative effect caused by receptor dimerization. Diabetes 2003; 52: 2984-2988
5. Blum WF, Englaro P, Hanitsch S et al. Plasma leptin levels in healthy children and adolescents. Dependence on body mass index, body fat mass, gender, pubertal stage and testosterone. J Clin Endocrinol Metab 1997; 822: 904-910
6. Blum WF, W Kiess, Rascher W. Leptin - The voice of adipose tissue. Leptin: Reference ranges of serum leptin levels according to body mass index, gender, and developmental stage. Edition J&J. JA Barth Verlag 1997
7. Blundell JE, Mac Diarmid JI. Fat as a risk for overconsumption: satiation, satiety, and patterns of eating. J Am Diet Assoc 1997; 97: S63-S69
8. Caro JF, Kolaczyski JW, Nyce MR, Ohannesian JP, Opentanova I, Goldman WH, Lynn RB, Zhang PL, Sinha MK, Considine RV. Decreased cerebrospinal-fluid/serum leptin ratio in obesity: a possible mechanism for leptin resistance. Lancet 1996; 348: 159-161
9. Cheung CC, Clifton DK, Steiner RA. Proopiomelanocortin neurons are direct targets for leptin in the hypothalamus. Endocrinology 1997; 138: 4489-4492
10. Dubern B, Clement K, Pelloux V, Froguel P, Giradet JP, Guy-Grand B, Tounian P. Mutational analysis of melanocortin-4 receptor, agouti-related protein, and alpha-melanocyte-stimulating hormone genes in severly obese children. J Pediatr 2001; 139: 2004-2009
11. Farooqi IS, Yeo GSH, Keogh JM, Aminian S, Jebb SA, Butler G, Cheetham T, O'Rahilly S. Dominant and recessive inheritance of morbid obesity associated with melanocortin4 receptor deficiency. J Clin Invest 2000; 106: 271-279
12. Ferro-Luzzi A, Martino L. Obesità and physical activity. Review. Ciba Found Symp 1996; 201: 207-221
13. Gantz I, Miwa H et al. Molecular cloning expression, and gene localization of a fourth melanocortin receptor. J Biol Chem 1993; 268: 15174-15179
14. Geller F, Reichwald K, Dempfle A, Illig T, Vollmert C, Herpertz S, Siffert W, Platzer M, Hess C, Gudermann T, Biebermann H, Wichmann HE, Schafer H, Hinney A, Hebebrand J. Melanocortin-4 receptor gene variant I103 is negatively associated with obesity. Am J Hum Genet 2004; 74: 572-581
15. Gu W, Tu Z et al. Identification and functional analysis of novel human melanocortin-4 receptor variants. Diabetes 1999; 48: 635-639
16. Heinze E, Holl RW. Test of β-cell function in childhood and adolescence. In: Ranke MB (Hrsg). Diagnostics of endocrine function in children and adolescents. 3rd ed. Karger, Basel 2003
17. Heinze E, Horn T, Wabitsch M, Wudy S, Sorgo W, Homoki J. Bestimmung von Insulinresistenz und Insulinsensitivität bei Kindern und Jugendlichen. Monatsschr Kinderheilkd 2002; 150: 1095-1100
18. Herpertz S, Siffert W, Hebebrand J. Binge eating as a phenotype of melanocortin 4 receptor gene mutations. N Engl J Med 2003; 349: 606-609
19. Hinney A, Hohmann S, Geller F, Vogel C, Hess C, Wermter AK, Brokamp B, Goldschmidt H, Siegfried W, Remschmidt H, Schafer H, Gudermann T, Hebebrand J. Melanocortin-4 receptor gene: case-control study and transmission disequilibrium test confirm that functionally relevant mutations are compatible with a major gene effect for extreme obesity. J Clin Endocrinol Metab 2003; 88: 4258-4267
20. Hinney A, Schmidt A, Notteborn K et al. Several mutations in the melanocortin-4 receptor gene including a nonsense and a frameshift mutation associated with dominantly inherited obesity in humans. J Clin Endocrinol Metab 1999; 84: 1483-1486
21. Jacobson P, Ukkola O, Rankinen T, Snyder EE, Leon AS, Rao DC, Skinner JS, Wilmore JH, Lonn L, Cowan Jr GS, Sjostrom L, Bouchard C. Melanocortin4 receptor sequence variations are seldom a cause of human obesity: the Swedish obese subjects, the HERITAGE family study, and a Memphis cohort. J Clin Endocrinol Metab 2002; 87: 4438-4441
22. Larsen LH, Echwald SM, Sorensen TI, Andersen T, Wulff BS, Pedersen O. Prevalence of mutations and functional analyses of melanocortin 4 receptor variants identified among 750 men with juvenile-onset obesity. J Clin Endocrinol Metab 2005; 90: 219-224
23. Lubrano-Berthelier C, Durand E, Dubern B, Shapiro A, Dazin P, Weill J, Perron C, Froguel P, Vaisse C. Intracellular retention is a common characteristic of childhood obesity-associated MC4R mutations. Hum Mol Genet 2003; 12: 145-153
24. MacNeil DJ et al. The role of melanocortins in body weight regulation: opportiunities for the treatment of obesity. Eur J Pharmacol 2002; 440: 141-157
25. Marti A, Corbalan MS, Forga L, Martinez JA, Hinney A, Hebebrand J. A novel nonsense mutation in the melanocortin-4 receptor associated with obesity in a Spanish population. Int J Obes Relat Metab Disord 2003; 27: 385-388
26. Miraglia Del Giudice E, Cirillo G, Nigro V, Santoro N, D'Urso L, Raimondo P, Cozzolino D, Scafato D, Perrone L. Low frequency of melanocortin-4 receptor (MC4R) mutations in a mediterranean population with early-onset obesity. Int J Obes Relat Metab Disord 2002; 26: 647-651
27. Nijenhuis WA et al. Poor cell surface expression of human melanocortin-4 receptor mutations associated with obesity. J Biol Chem 2003; 278: 22939-22945
28. Perusse I, Tremblay A, Leblanc C, Bouchard C. Genetic and environmental influences on level of habitual physical activity and exercise participation. Am J Epidemiol 1989; 129: 1012-1022
29. Raab M, Hinney A, Grassl W, Remschmidt H, Hebebrand J. Bedeutung des melanokortinergen Systems für die Gewichtsregulation. Dtsch Med Wochenschr 2003; 128: 447-452
30. Rohner-Jeanrenaud F, Cusin I, Siansbury A, Zakrzewska KE, Jeanrenaud B. The loop system beteween neuropeptide Y and leptin in normal and obese rodents. Horm Metab Res 1996; 28: 642-648
31. Sina M, Hinney A, Ziegler A et al. Phenotypes in three pedigrees with autosomal dominant obesity caused by happloinsufficiency mutations in the melanocortin-4 receptor gene. Am J Hum Genet 1999; 65: 1501-1507
32. Stumvoll M et al. Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care 2000; 23: 295-301
33. Tritos NA, Maratos-Flier E. Two important systems in energy homeostasis: melanocortins and melanin-concentrating hormone. Neuropeptides 1999;33:339-349
34. Vaisse C, Clement K, Durand E, Hercberg S, Guy-Grand B, Froguel P. Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity. J Clin Invest 2000; 106: 253-262
35. Valli-Jaakola K, Lipsanen-Nyman M, Oksanen L, Hollenberg AN, Kontula K, Bjorbaek C, Schalin-Jantti C. Identification and characterization of melanocortin-4 receptor gene mutations in morbidly obese finnish children and adults. J Clin Endocrinol Metab 2004; 89: 940-945
36. Wabitsch M, Kunze D. Adipositas im Kindes- und Jugendalter. Basis-informationen und Leitlinien für Diagnostik, Therapie und Prävention. Monatsschr Kinderheilkd 2001; 149: 805-806
37. Williams CL, Hayman LL et al. Cardiovascular health in childhood: A Statement for health professionals from the Committee on atherosclerosis, hypertension and obesity in the young (AHOY). Circulation 2002; 106: 143-160
38. Yeo GS, Lank EJ, Farooqi IS, Keogh J, Challis BG, O'Rahilly S. Mutations in the human melanocortin-4 receptor gene associated with severe familial obesity disrupts receptor function through multiple molecular mechanisms. Hum Mol Genet 2003; 12: 561-574